Cripto-1 Promotes the Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma Cells

被引:9
作者
Huang, Chun [1 ]
Chen, Wangsheng [2 ]
Wang, Xiaowen [3 ]
Zhao, Jinqiu [4 ]
Li, Qian [5 ]
Fu, Zhongxue [6 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Chongqing 400016, Peoples R China
[2] Luzhou Med Coll, Affiliated Hosp, Dept Gen Surg, Luzhou, Peoples R China
[3] Shanghai Jiao Tong Univ Med, Shanghai, Peoples R China
[4] Chongqing Med Univ, Affiliated Hosp 1, Dept Resp Surg, Chongqing 400016, Peoples R China
[5] Fifth Peoples Hosp, Dept Neurol, Chongqing, Peoples R China
[6] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Chongqing 400016, Peoples R China
关键词
LUNG-CANCER; DNA-REPAIR; EXPRESSION; GENE;
D O I
10.1155/2015/421285
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Esophageal carcinoma is a major public health problem worldwide and one of the most aggressively malignant neoplasms. Although considerable diagnostic and therapeutic progress has been made in recent years, the prognosis of EC patients still remains dismal due to high rates of recurrence/metastasis and invasion. Previous studies have demonstrated that Epithelial mesenchymal transition (EMT) is proposed as a critical mechanism for the acquisition of malignant phenotypes by epithelial cells. Several lines of evidence have shown that Cripto-1 plays an important oncogenic role during tumorigenesis by promoting EMT. The aim of our study was to evaluate the significance of Cripto-1 which plays a role in EMT and its metastasis in esophageal carcinoma. Data of this study suggest that Cripto-1 overexpression is connected with the tumorigenesis and progression of esophageal carcinoma; shRNA might be feasible for the inhibition of the invasion and metastasis of esophageal carcinoma.
引用
收藏
页数:13
相关论文
共 24 条
  • [1] Cripto: A tumor growth factor and more
    Adamson, ED
    Minchiotti, G
    Salomon, DS
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 190 (03) : 267 - 278
  • [2] Ando N., 2007, DIFFICULT DECISIONS, P265
  • [3] Identification of Cripto-1 as a novel serologic marker for breast and colon cancer
    Bianco, Caterina
    Strizzi, Luigi
    Mancino, Mario
    Rehman, Aasia
    Hamada, Shin
    Watanabe, Kazuhide
    De Luca, Antonella
    Jones, Brenda
    Balogh, Gabriela
    Russo, Jose
    Mailo, Daniel
    Palaia, Raffaele
    D'Aiuto, Giuseppe
    Botti, Gerardo
    Perrone, Francesco
    Salomon, David S.
    Normanno, Nicola
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (17) : 5158 - 5164
  • [4] Targeting the embryonic gene Cripto-1 in cancer and beyond
    Bianco, Caterina
    Salomon, David S.
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (12) : 1739 - 1749
  • [5] [陈旺盛 Chen Wangsheng], 2013, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V38, P288
  • [6] Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
    Chou, Ting-Chao
    [J]. CANCER RESEARCH, 2010, 70 (02) : 440 - 446
  • [7] Human recombinant Cripto-1 increases doubling time and reduces proliferation of HeLa cells independent of pro-proliferation pathways
    Das, Asim Bikas
    Loying, Pojul
    Bose, Biplab
    [J]. CANCER LETTERS, 2012, 318 (02) : 189 - 198
  • [8] de Castro NP, 2010, FUTURE ONCOL, V6, P1127, DOI [10.2217/fon.10.68, 10.2217/FON.10.68]
  • [9] Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    Ferlay, Jacques
    Shin, Hai-Rim
    Bray, Freddie
    Forman, David
    Mathers, Colin
    Parkin, Donald Maxwell
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (12) : 2893 - 2917
  • [10] Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity
    Hongo, Michio
    Nagasaki, Yutaka
    Shoji, Tomotaka
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (05) : 729 - 735